The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Feb 2019)
Editorial: IL-1 Inhibition
Francesca Oliviero,
Paolo Sfriso,
Leonardo Punzi,
Jean-Michel Dayer
Affiliations
Francesca Oliviero
Rheumatology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
Paolo Sfriso
Rheumatology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
Leonardo Punzi
Rheumatology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
Jean-Michel Dayer
Faculty of Medicine, University of Geneva, Geneva, Switzerland
DOI
https://doi.org/10.3389/fphar.2019.00087
Journal volume & issue
Vol. 10
Abstract
Read online
No abstracts available.
Keywords
IL-1 (interleukin-1)
IL-1 blockade
anakinra
canakinumab
rheumatic diseases
inflammatory chronic diseases
WeChat QR code
Close